EHNA hydrochloride
≥98%
- Product Code: 64923
CAS:
58337-38-5
| Molecular Weight: | 313.83 g./mol | Molecular Formula: | C₁₄H₂₄ClN₅O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
EHNA hydrochloride is primarily used in biochemical research as a potent and selective inhibitor of adenosine deaminase (ADA). This enzyme plays a crucial role in purine metabolism, and its inhibition is studied to understand various physiological and pathological processes. Researchers utilize EHNA hydrochloride to investigate the role of adenosine in immune regulation, inflammation, and cancer biology. It is also employed in studies focusing on the therapeutic potential of ADA inhibition in diseases such as leukemia and other hematological disorders. Additionally, EHNA hydrochloride aids in exploring the effects of adenosine accumulation in cardiovascular and neurological systems, providing insights into potential treatments for conditions like ischemia and epilepsy. Its application extends to drug development, where it serves as a tool to evaluate the efficacy of new ADA-targeting compounds.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿22,500.00 |
+
-
|
EHNA hydrochloride
EHNA hydrochloride is primarily used in biochemical research as a potent and selective inhibitor of adenosine deaminase (ADA). This enzyme plays a crucial role in purine metabolism, and its inhibition is studied to understand various physiological and pathological processes. Researchers utilize EHNA hydrochloride to investigate the role of adenosine in immune regulation, inflammation, and cancer biology. It is also employed in studies focusing on the therapeutic potential of ADA inhibition in diseases such as leukemia and other hematological disorders. Additionally, EHNA hydrochloride aids in exploring the effects of adenosine accumulation in cardiovascular and neurological systems, providing insights into potential treatments for conditions like ischemia and epilepsy. Its application extends to drug development, where it serves as a tool to evaluate the efficacy of new ADA-targeting compounds.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :